Facebook pixel

Program Lead
Early Development Oncology
Confirmed live in the last 24 hours
Vancouver, BC, Canada
Experience Level
  • Following program progression of various targets from beginning to end while closely collaborating with groups across the organization
  • Directing the strategy for data generation and using these data to support lead therapeutic selection for specific programs
  • Becoming a world expert on specific targets in oncology by researching the literature, establishing connections with key opinion leaders, attending scientific conferences and generating data
  • Designing and interpreting complex biological experiments to execute the strategy
  • Training and mentoring scientists
  • You are strongly self-motivated and work independently to identify project needs and follow that up with building and implementing solutions
  • You know how to lead program progression, from target inception to final lead candidate and can coordinate the activities of all of the contributing teams
  • You are flexible and scientifically nimble and want to become an expert in the biology of the targets for which you are responsible
  • You are driven to help build and execute on drug development plans
  • A PhD in Oncology or Immunology or related field and 10+ years of experience
  • Experience leading antibody or protein-based oncology therapeutic programs through drug development and with selecting a final lead candidate
  • Experience writing and coordinating formal reports to support regulatory documents
  • Exposure to regulatory agency submissions and understanding of the components of regulatory documents
  • Strong interpersonal skills with the ability to work collaboratively as a member of a cross-functional team
  • Excellent documentation and organizational skills
  • Superb verbal and written communication skills, including public presentation of complex data
AbCellera Biologics
Company Overview
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.